Want to see TSE:MUSH full AI Analyst Report?
Top Page
Good Shroom Co Inc
(MUSH)
Select Model
Select Model
Rating:60Neutral
Price Target:
C$0.13
▲(17.27% Upside)
Action:Reiterated
Date:07/01/26
The score is primarily driven by improving financial performance (strong revenue rebound, positive operating earnings, and positive cash flow) and supportive price trends (trading above key moving averages). These positives are tempered by still-thin profitability and weaker valuation signals due to a negative P/E and no dividend yield data.
Positive Factors
Strong Revenue Rebound
The sharp TTM revenue rebound indicates improving commercial traction and product demand. If sustained, this broader revenue base can support operating leverage and create a stronger foundation for durable profitability.
Negative Factors
Thin and Inconsistent Profitability
Revenue growth has not yet translated into durable bottom-line profitability. Thin operating margins and a slightly negative net margin leave limited protection against cost increases, weaker demand, or execution setbacks.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Rebound
The sharp TTM revenue rebound indicates improving commercial traction and product demand. If sustained, this broader revenue base can support operating leverage and create a stronger foundation for durable profitability.
Read all positive factors
Good Shroom Co Inc (MUSH) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$5.84M
Dividend YieldN/A
Average Volume (3M)4.38K
Price to Earnings (P/E)―
Beta (1Y)0.99
Revenue Growth52.89%
EPS Growth98.68%
CountryCA
Employees5
SectorGeneral
Sector StrengthN/A
IndustryBeverages - Non-Alcoholic
Share Statistics
EPS (TTM)<0.01
Shares Outstanding51,674,683
10 Day Avg. Volume6,600
30 Day Avg. Volume4,379
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)16.94
Price to Sales (P/S)1.37
P/FCF Ratio19.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Good Shroom Co Inc Business Overview & Revenue Model
Company Description
Mercanto Holdings Inc. specializes in the creation, production, and distribution of convenient wellness drinks. Its product range thoughtfully incorporates ingredients such as traditional cannabis, beneficial probiotics, and specialized functional...
How the Company Makes Money
Detailed, company-specific information describing Good Shroom Co Inc (MUSH)’s revenue model (e.g., primary revenue streams, product/service monetization, licensing/royalties, distribution arrangements, and significant partnerships) is not availabl...
Good Shroom Co Inc Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
70
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.52M | 3.00M | 3.89M | 3.16M | 1.22M | 242.13K |
| Gross Profit | 941.96K | 621.69K | 1.23M | 665.12K | 228.64K | 61.90K |
| EBITDA | 63.26K | -390.16K | 66.24K | -427.19K | -1.56M | -3.56M |
| Net Income | -6.81K | -412.31K | 40.60K | -452.14K | -1.63M | -3.85M |
Balance Sheet | ||||||
| Total Assets | 1.69M | 1.02M | 1.48M | 1.44M | 1.64M | 2.30M |
| Cash, Cash Equivalents and Short-Term Investments | 542.38K | 394.97K | 202.37K | 378.42K | 751.55K | 1.69M |
| Total Debt | 67.38K | 0.00 | 17.53K | 74.06K | 207.78K | 258.46K |
| Total Liabilities | 1.19M | 778.53K | 899.77K | 986.48K | 881.55K | 495.21K |
| Stockholders Equity | 495.86K | 242.01K | 583.10K | 457.57K | 762.81K | 1.80M |
Cash Flow | ||||||
| Free Cash Flow | 461.46K | 210.60K | -148.04K | -355.13K | -777.78K | -1.73M |
| Operating Cash Flow | 461.46K | 210.60K | -148.04K | -355.13K | -777.78K | -1.71M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 70.00K | 0.00 | 2.58M |
| Financing Cash Flow | -12.22K | -18.00K | -28.02K | -18.00K | -160.00K | 247.13K |
Good Shroom Co Inc Technical Analysis
Negative
0.11
Price Trends
0.13
Negative
0.13
Negative
0.14
Negative
Market Momentum
>-0.01
Negative
43.89
Neutral
22.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MUSH, the sentiment is Negative. The current price of 0.11 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.13, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.89 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MUSH.
Good Shroom Co Inc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | C$5.84M | -600.00 | -2.30% | ― | 52.89% | 98.68% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | C$10.46M | -1.04 | 288.66% | ― | ― | -162.50% | |
42 Neutral | C$24.65M | -3.88 | -338.76% | ― | ― | 31.00% | |
41 Neutral | C$11.21M | -2.94 | 28.59% | ― | 0.90% | 57.73% |
* General Sector Average
TSE:MUSH
Good Shroom Co Inc
0.12
0.05
60.00%
TSE:RVV
Revive Therapeutics
0.03
<0.01
25.00%
TSE:PCLO
PharmaCielo
0.06
0.01
22.22%
TSE:LOBE
Lobe Sciences
0.08
0.04
100.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.